Multilab-Logo, India
 New No.3, Appaiar Lane, Second Floor, Royapuram, Chennai - 600 013, Tamilnadu, India
 Email - 0, Phone - +9144 25984175,  Mobile - +91 94441 62346    
Language    Search
  Cleanrooms Laboratory
  Pharmaceutical Testing



Frequently Asked Question - Biological Safety
 
Pharma ,Cleanroom Glossary of Terms

Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

Cleanroom Question Bank
fed 209e,iso14644-1,euggmp,iso14698
Cleanroom Disciplines and etc ..


   Special Practices for Biological Safety 2 / Biosafety Level 2 - BSL 2   
Special Practices for Biological Safety 2 / Biosafety Level 2 - BSL 2

  1. Access to the laboratory is limited or restricted by the principal investigator when work with infectious agents is in progress. In general, persons at increased risk of acquiring infection or for whom infection may be unusually hazardous are not allowed in the laboratory or animal rooms. Persons who are immunocompromised or immunosuppressed may be at unusual risk of acquiring infections.

  2. The principal investigator establishes policies and procedures whereby only persons who have been advised of the potential hazard and meet specific requirements (e.g., immunization) enter the laboratory or animal rooms.

  3. When an infectious agent requires special provisions (e.g., immunization) for entering a laboratory where it is in use, a hazard warning sign incorporating the universal biohazard symbol is posted on the access door to the laboratory work area. The hazard warning sign identifies the infectious agent, lists the name and telephone number of the principal investigator or other responsible person, and indicates the special requirements for entering the laboratory. propriate immunizations for the agents handled or potentially present in the laboratory.

  4. When appropriate, baseline serum samples for laboratory and other at-risk personnel are collected and stored. Additional specimens may be collected periodically.

  5. A biosafety manual shall be developed for the laboratory. Laboratory personnel are advised of special hazards and are required to read and follow instructions on practices and procedures.

  6. Laboratory personnel receive appropriate training on the potential hazards associated with the work involved, the necessary precautions to prevent exposures, and the exposure evaluation procedures. Personnel receive annual retraining and receive additional training when procedures or policies change.

  7. A high degree of precaution must always be taken with any contaminated sharp items, including needles and syringes, slides, pipettes, capillary tubes, and scalpels. Needles and syringes should be used in the laboratory only when there is no alternative, such as when parenteral injection, phlebotomy, or aspiration of fluids from laboratory animals and diaphragm bottles are conducted. Plasticware should be substituted for glassware whenever possible.

    1. Only needle-locking syringes or disposable syringe-needle units (i.e., the needle is integral to the syringe) are used for injection or aspiration of infectious materials. Used disposable needles must not be bent, sheared, broken, recapped, removed from disposable syringes, or otherwise manipulated by hand before disposal; rather they must be carefully placed in conveniently located puncture-resistant containers used for sharps disposal. Nondisposable sharps must be placed in a hard-walled container for transport to a processing area for decontamination, preferably by autoclaving.

    2. Syringes that resheathe the needle, needleless systems, and other safe devices should be used when appropriate.

    3. Broken glassware must not be handled directly by hand but must be removed by mechanical means such as a brush and dustpan, tongs, or forceps. Containers of contaminated needles, sharp equipment, and broken glass are decontaminated before disposal.

  8. Cultures, tissues, and specimens of body fluids are placed in a container that prevents leakage during collection, handling, processing, storage, transport, or shipping.

  9. Laboratory equipment and work surfaces should be decontaminated with an appropriate disinfectant on a routine basis as well as after work with infectious material is finished and, especially, after overt spills, splashes, or other contamination by infectious materials. Contaminated equipment must be decontaminated before it is sent for repair or maintenance or packaged for transport.

  10. Spills or accidents that result in overt exposures to infectious materials are immediately reported to the laboratory director. Medical evaluation, surveillance, and treatment are provided as appropriate at no cost to employees, and written records are maintained.

  11. Animals not involved in the work being performed are not permitted in the lab.